Literature DB >> 22418060

Motor function and dopamine release measurements in transgenic Huntington's disease model rats.

Andrea N Ortiz1, Gregory L Osterhaus, Kelli Lauderdale, Luke Mahoney, Stephen C Fowler, Stephan von Hörsten, Olaf Riess, Michael A Johnson.   

Abstract

Huntington's disease (HD) is a fatal, genetic, neurodegenerative disorder characterized by deficits in motor and cognitive function. Here, we have quantitatively characterized motor deficiencies and dopamine release dynamics in transgenic HD model rats. Behavioral analyses were conducted using a newly-developed force-sensing runway and a previously-developed force-plate actometer. Gait disturbances were readily observed in transgenic HD rats at 12 to 15months of age. Additionally, dopamine system challenge by ip injection of amphetamine also revealed that these rats were resistant to the expression of focused stereotypy compared to wild-type controls. Moreover, dopamine release, evoked by the application of single and multiple electrical stimulus pulses applied at different frequencies, and measured using fast-scan cyclic voltammetry at carbon-fiber microelectrodes, was diminished in transgenic HD rats compared to age-matched wild-type control rats. Collectively, these results underscore the potential contribution of dopamine release alterations to the expression of motor impairments in transgenic HD rats.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418060      PMCID: PMC3677762          DOI: 10.1016/j.brainres.2012.02.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

1.  Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice.

Authors:  A Petersén; Z Puschban; J Lotharius; B NicNiocaill; P Wiekop; W T O'Connor; P Brundin
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

2.  Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies.

Authors:  Stephen C Fowler; Brenda Birkestrand; Rong Chen; Elena Vorontsova; Troy Zarcone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

Review 3.  Mouse models of Huntington's disease.

Authors:  Liliana B Menalled; Marie-Françoise Chesselet
Journal:  Trends Pharmacol Sci       Date:  2002-01       Impact factor: 14.819

4.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

5.  Transgenic rat model of Huntington's disease.

Authors:  Stephan von Hörsten; Ina Schmitt; Huu Phuc Nguyen; Carsten Holzmann; Thorsten Schmidt; Thomas Walther; Michael Bader; Reinhard Pabst; Philipp Kobbe; Jana Krotova; Detlef Stiller; Ants Kask; Annika Vaarmann; Silvia Rathke-Hartlieb; Jörg B Schulz; Ute Grasshoff; Ingrid Bauer; Ana Maria Menezes Vieira-Saecker; Martin Paul; Lesley Jones; Katrin S Lindenberg; Bernhard Landwehrmeyer; Andreas Bauer; Xiao-Jiang Li; Olaf Riess
Journal:  Hum Mol Genet       Date:  2003-03-15       Impact factor: 6.150

Review 6.  Knock-in mouse models of Huntington's disease.

Authors:  Liliana B Menalled
Journal:  NeuroRx       Date:  2005-07

7.  Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

Authors:  E Scherzinger; R Lurz; M Turmaine; L Mangiarini; B Hollenbach; R Hasenbank; G P Bates; S W Davies; H Lehrach; E E Wanker
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

8.  Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus.

Authors:  H G Lüesse; J Schiefer; A Spruenken; C Puls; F Block; C M Kosinski
Journal:  Behav Brain Res       Date:  2001-11-29       Impact factor: 3.332

9.  Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats.

Authors:  Stephen C Fowler; Jonathan W Pinkston; Elena Vorontsova
Journal:  Psychopharmacology (Berl)       Date:  2007-02-06       Impact factor: 4.415

10.  Synaptic vesicle pools: an update.

Authors:  Annette Denker; Silvio O Rizzoli
Journal:  Front Synaptic Neurosci       Date:  2010-10-05
View more
  13 in total

1.  Regional differences in dopamine release in the R6/2 mouse caudate putamen.

Authors:  Sam V Kaplan; Ryan A Limbocker; Beth Levant; Michael A Johnson
Journal:  Electroanalysis       Date:  2018-03-30       Impact factor: 3.223

2.  5-Fluorouracil impairs attention and dopamine release in rats.

Authors:  David P Jarmolowicz; Rachel Gehringer; Shea M Lemley; Michael J Sofis; Sam Kaplan; Michael A Johnson
Journal:  Behav Brain Res       Date:  2019-01-07       Impact factor: 3.332

Review 3.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

4.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 5.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

6.  Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington's disease.

Authors:  Garnik Akopian; Joshua Barry; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci Res       Date:  2016-09-12       Impact factor: 4.164

Review 7.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

8.  Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility.

Authors:  Jane Y Chen; Elizabeth A Wang; Carlos Cepeda; Michael S Levine
Journal:  Front Neurosci       Date:  2013-07-04       Impact factor: 4.677

Review 9.  Corticostriatal Dysfunction in Huntington's Disease: The Basics.

Authors:  Kendra D Bunner; George V Rebec
Journal:  Front Hum Neurosci       Date:  2016-06-28       Impact factor: 3.169

10.  Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.

Authors:  Sam V Kaplan; Ryan A Limbocker; Rachel C Gehringer; Jenny L Divis; Gregory L Osterhaus; Maxwell D Newby; Michael J Sofis; David P Jarmolowicz; Brooke D Newman; Tiffany A Mathews; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2016-05-22       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.